Federal Select Agent Program

Federal Select Agent Program
Name	Federal Select Agent Program
Formation	1996
Headquarters	United States
Parent organization	United States Department of Health and Human Services; United States Department of Agriculture

Federal Select Agent Program The Federal Select Agent Program administers regulations governing possession, transfer, and use of designated biological agents and toxins in the United States. It coordinates policy among United States Department of Health and Human Services, United States Department of Agriculture, Centers for Disease Control and Prevention, and Animal and Plant Health Inspection Service, with statutory authorities derived from landmark statutes and responses to major biological events. The program intersects with institutions involved in public health, biosecurity, and biodefense.

Overview

The program consolidates oversight responsibilities among Centers for Disease Control and Prevention, Animal and Plant Health Inspection Service, Department of Homeland Security, Federal Bureau of Investigation, National Institutes of Health, and Office of Inspector General (United States Department of Health and Human Services) to regulate possession and transfer of agents listed pursuant to the Public Health Security and Bioterrorism Preparedness and Response Act of 2002 and subsequent rulemaking. It affects operations at Harvard University, Johns Hopkins University, Massachusetts Institute of Technology, Fort Detrick, Wadsworth Center, Los Alamos National Laboratory, Centers for Disease Control and Prevention (CDC) Emergency Operations Center and other research, clinical, agricultural, and commercial entities. Coordination involves links with National Academies of Sciences, Engineering, and Medicine, World Health Organization, National Institutes of Health (NIH) Office of Science Policy, and interagency policy bodies.

Regulatory Framework and Authorities

Primary statutory foundations include the Antiterrorism and Effective Death Penalty Act of 1996, the Public Health Security and Bioterrorism Preparedness and Response Act of 2002, and implementing regulations codified at Code of Federal Regulations sections administered by Centers for Disease Control and Prevention and Animal and Plant Health Inspection Service. Enforcement interfaces with the Federal Food, Drug, and Cosmetic Act, Agricultural Bioterrorism Protection Act of 2002, and investigative authorities exercised by the Federal Bureau of Investigation and Department of Justice. The regulatory framework also intersects with grant conditions from the National Institutes of Health, export controls by the Bureau of Industry and Security, and biosafety guidance from the Occupational Safety and Health Administration and World Organisation for Animal Health.

Covered Agents and Toxins

The select agent and toxin lists enumerate pathogens and toxins such as Bacillus anthracis, Clostridium botulinum toxin, Variola virus, Yersinia pestis, Francisella tularensis, and other agents affecting humans, animals, and plants like Xylella fastidiosa and Phytophthora ramorum. The lists are periodically updated pursuant to risk assessments informed by analyses from Centers for Disease Control and Prevention Division of High-Consequence Pathogens and Pathology, United States Department of Agriculture Animal and Plant Health Inspection Service Biology Division, and advisory input from bodies such as the Advisory Committee on Immunization Practices and panels convened by the National Science Advisory Board for Biosecurity. Classification decisions consider factors studied in outbreaks such as 2001 anthrax attacks and historic events like 1918 influenza pandemic.

Registration and Compliance Requirements

Entities possessing select agents must register with the appropriate agencies, maintain detailed inventories, implement biosafety and biosecurity measures, and designate accountable officials such as Responsible Officials and Alternate Responsible Officials. Registration procedures reference standards from Centers for Disease Control and Prevention Biosafety in Microbiological and Biomedical Laboratories, institutional review conducted by Institutional Biosafety Committee and personnel vetting involving the Federal Bureau of Investigation Biometric and Identity Services. Funding and credentialing pathways often involve institutions like National Institutes of Health, Department of Defense, Walter Reed Army Institute of Research, and university compliance offices at University of California, San Francisco and Yale University.

Security, Safety, and Incident Reporting

Mandated security risk assessments, access control plans, and biosafety training link to guidance from Occupational Safety and Health Administration, Department of Homeland Security Office of Health Affairs, and Federal Emergency Management Agency. Incident reporting requirements obligate rapid notification for theft, loss, or release to agencies including Centers for Disease Control and Prevention, Animal and Plant Health Inspection Service, and Federal Bureau of Investigation, with coordination for public health response involving State health departments and agencies such as New York City Department of Health and Mental Hygiene and Los Angeles County Department of Public Health.

Inspections and Enforcement Actions

Routine and unannounced inspections are conducted by teams from Centers for Disease Control and Prevention and Animal and Plant Health Inspection Service; enforcement actions may include suspension or revocation of registration, administrative actions, and referral to Department of Justice for criminal prosecution. High-profile compliance investigations have involved scrutiny at laboratories affiliated with University of Wisconsin–Madison, Duke University, Boston University, and national laboratories such as Oak Ridge National Laboratory. Civil enforcement can involve penalties guided by Code of Federal Regulations and coordination with the Office of Management and Budget for rulemaking impact analyses.

Historical Development and Major Incidents

The program evolved from pre-2001 legislative frameworks and was substantially reshaped after the 2001 anthrax attacks, when Congress enacted the Bioterrorism Preparedness Act and regulatory agencies promulgated the select agent rules. Major incidents informing policy include laboratory-acquired infections documented at institutions like US Army Medical Research Institute of Infectious Diseases, disclosure events at Centers for Disease Control and Prevention facilities, and agricultural outbreaks such as 2001 foot-and-mouth disease outbreak and 2002 exotic Newcastle disease outbreak. Reviews and reports by Government Accountability Office, National Research Council (United States), and inspector general offices have driven iterative reforms.

Category:United States federal boards, commissions, and committees